Radioimmunoassay of Parathyroid Hormone in Human Plasma and Tissue Using Commercially Available Antiserum and Modified Iodination
スポンサーリンク
概要
- 論文の詳細を見る
The human PTH radioimmunoassay has been developed by use of bovine PTH and anti-bovine PTH antiserum, both of which were commercially available. The iodination process was modified as to use acid solution resulting in the more stable <SUP>125</SUP>I-PTH. However, the PTH radioimmunoassay employed this antiserum with <SUP>125</SUP>I-bovine PTH revealed that the N-terminal portion of PTH molecule was reactive only slightly in this system, indicating that most of PTH determined by this radioimmunoassay might be an biologically inactive PTH.<BR>Plasma from normal subjects and patients with primary hyperparathyroidism or uremia showed dilutional curves parallel to the curve of the standard bovine PTH, indicating the immunological identity between human and bovine PTH in this radioimmunoassay system. The extract from the parathyroid adenoma showed an identical dilutional curve, but the extract from the ectopic PTH producing tumor showed a different dilutional curve from that of the standard PTH, which might indicate the immunochemical heterogeneity of PTH produced from the ectopic source. Plasma PTH levels obtained from normal subjects and patients with primary hyperparathyroidism, uremia or pseudohypoparathyroidism were compatible with those reported previously. These data indicate that the human PTH radioimmunoassay can be done by use of commercially available anti-bovine PTH antiserum and bovine PTH in conjunction with the modified iodination process and double antibody method. However, this assay was directed mainly to the C-terminal portion of PTH molecule and the PTH radioimmunoassay specific for the N-terminal portion will be required to evaluate the PTH regulation more precisely in man.
- 社団法人 日本内分泌学会の論文
著者
-
Abe Kaoru
Endocrine Division National Cancer Center
-
KUMAOKA SOICHI
Endocrine Division, National Cancer Center Research Institute
-
ADACHI ISAMU
Endocrine Division, National Cancer Center Research Institute
-
MIYAKAWA SUMIKO
Endocrine Division, National Cancer Center Research Institute
-
TANAKA MASAHIRO
Endocrine Division, National Cancer Center Research Institute and Clinical Biochemistry
関連論文
- Plasma Gastrin Levels and Gastric Acid Secretion in Chronic Renal Failure
- IMMUNOHISTOCHEMICAL AND IMMUNOCYTOCHEMICAL LOCALIZATION OF ATRIAL NATRIURETIC POLYPEPTIDE IN HUMAN ADULT AND FETAL HEARTS
- Cushings Syndrome due to Huge Adrenocortical Multinodular Hyperplasia
- Substance P Radioimmunoassay Using Nα-Tyrosyl-substance P and Demonstration of the Presence of Substance P-like Immunoreactivities in Human Blood and Porcine Tissue Extracts
- Effect of L-Dopa on Anterior Pituitary Hormone Release in Man
- Long-term Administration of 3, 5-Diodo-4 (3-iodo4-acetoxyphenoxy) Benzoic Acid (Acetiromate) in Hyperlipidemic Patients
- Plasma Human Calcitonin (hCT) Levels in Normal and Pathologic Conditions, and their Responses to Short Calcium or Tetragastrin Infusion
- Phosphaturic Effect of I. V. Administered Calcitonin in Man
- Radioimmunoassay Specific for Amino (N) and Carboxyl (C) Terminal Portion of Parathyroid Hormone
- Radioimmunoassay of Parathyroid Hormone in Human Plasma and Tissue Using Commercially Available Antiserum and Modified Iodination
- Inhibitory effect of calcium channel blockers on .ALPHA.-adrenergic activation of glycogenolysis and calcium efflux in perfused rat liver.